PGI19 COST-EFFECTIVENESS ANALYSIS OF TOFACITINIB FOR THE TREATMENT OF MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS IN GREECE
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.1142
https://www.valueinhealthjournal.com/article/S1098-3015(19)33520-X/fulltext
Title :
PGI19 COST-EFFECTIVENESS ANALYSIS OF TOFACITINIB FOR THE TREATMENT OF MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS IN GREECE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33520-X&doi=10.1016/j.jval.2019.09.1142
First page :
Section Title :
Open access? :
No
Section Order :
11001